Anixa Biosciences Inc (ANIX)
2.43
-0.11
(-4.33%)
USD |
NASDAQ |
May 31, 16:00
2.45
+0.02
(+0.82%)
After-Hours: 20:00
Anixa Biosciences Shareholders Equity (Quarterly): 24.60M for Jan. 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | 24.60M |
October 31, 2023 | 24.34M |
July 31, 2023 | 25.52M |
April 30, 2023 | 26.81M |
January 31, 2023 | 27.79M |
October 31, 2022 | 29.05M |
July 31, 2022 | 31.70M |
April 30, 2022 | 32.17M |
January 31, 2022 | 33.96M |
October 31, 2021 | 35.44M |
July 31, 2021 | 36.47M |
April 30, 2021 | 37.61M |
January 31, 2021 | 13.60M |
October 31, 2020 | 8.761M |
July 31, 2020 | 8.618M |
April 30, 2020 | 5.287M |
January 31, 2020 | 5.445M |
October 31, 2019 | 5.235M |
July 31, 2019 | 5.799M |
April 30, 2019 | 6.543M |
January 31, 2019 | 5.479M |
October 31, 2018 | 5.435M |
July 31, 2018 | 6.326M |
April 30, 2018 | 6.066M |
January 31, 2018 | 6.436M |
Date | Value |
---|---|
October 31, 2017 | 7.923M |
July 31, 2017 | 5.488M |
April 30, 2017 | 3.589M |
January 31, 2017 | -3.819M |
October 31, 2016 | 0.9875M |
July 31, 2016 | 1.718M |
April 30, 2016 | 2.560M |
January 31, 2016 | 3.591M |
October 31, 2015 | 5.054M |
July 31, 2015 | 5.998M |
April 30, 2015 | 6.990M |
January 31, 2015 | 8.258M |
October 31, 2014 | 4.010M |
July 31, 2014 | 0.1497M |
April 30, 2014 | -4.846M |
January 31, 2014 | -5.669M |
October 31, 2013 | -3.321M |
July 31, 2013 | -3.238M |
April 30, 2013 | -1.446M |
January 31, 2013 | -1.324M |
October 31, 2012 | -1.194M |
July 31, 2012 | -0.8931M |
April 30, 2012 | -0.339M |
January 31, 2012 | 0.738M |
October 31, 2011 | 1.058M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
5.235M
Minimum
Oct 2019
37.61M
Maximum
Apr 2021
22.01M
Average
25.52M
Median
Jul 2023
Shareholders Equity (Quarterly) Benchmarks
CEL-SCI Corp | 14.30M |
AIM ImmunoTech Inc | 4.826M |
IGC Pharma Inc | 9.053M |
NovaBay Pharmaceuticals Inc | 0.16M |
Protalix BioTherapeutics Inc | 29.79M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 25.37M |
Total Liabilities (Quarterly) | 1.768M |